Thom Labean News Today : Breaking News, Live Updates & Top S

Helixomer awarded $2M NIH grant for anticoagulant development | North Carolina Biotechnology Center

Published: December 14, 2023

Raleigh-based Helixomer, a pre-clinical, drug-development company created at North Carolina State University, has won a $2 million federal grant to advance a pair of novel drugs to regulate bleeding and clotting in patients.

Source: ncbiotech.org

Related Topics:

North Carolina State University North Carolina United States Abhichart Krissanaprasit Thom Labean Carolina Biotechnology Center Carolina State University Translational Research Grant Nc State Department Of Materials Science Small Business Research National Institutes Of Health Innovation Fund Raleigh Based Helixomer National Institutes North Carolina Biotechnology Center Flash Grant Small Business Research Loans Materials Science

Thom Labean News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Top News In Thom Labean Today - Breaking & Trending Today

Startup launched at NCSU lands $2M grant for drugs to regulate bleeding, clotting

Helixomer awarded $2M NIH grant for anticoagulant development | North Carolina Biotechnology Center